Edesa Biotech Inc. Common Shares (EDSA)
Stock · NASDAQ · Health Care
$2.57as of 10/16/2026
Price chart
Active signals
EDSA Signal Track Record
How signals performed across all stocks →What EDSA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 31 | -1.5% | 39% | September 30, 2026 |
| Bollinger Band BreakdownActive now | 23 | -0.7% | 48% | August 20, 2026 |
| Bollinger Band Breakout | 17 | -6.7% | 29% | April 21, 2026 |
| 200-Day Moving Average TouchActive now | 10 | -4.4% | 20% | August 4, 2025 |
| Any 20-session window (baseline) | -4.2% | 38% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About EDSA
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. It develops EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome; and EB01, a topical vanishing cream containing non-steroidal anti-inflam…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 17
- Website
- www.edesabiotech.com/
Fundamentals
- 1-day range
- $2.54$2.79
- Market cap
- $44.90M
- P/E (trailing)
- —
- P/E (forward)
- -1.38
- EPS (trailing)
- $-1.69
- Dividend yield
- —
- Beta
- 1.15
- Avg. volume
- 62.8K
- Dividend pay date
- June 10, 2019
How Edesa Biotech Inc. Common Shares Makes Money
Where the revenue actually goes — FY2020 annual results
Source: 10-K filed Dec 7, 2020 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
Edesa Biotech Inc. Common Shares Competitors
Chosen by industry and closest market cap.
- EDSAEdesa Biotech Inc. Common Shares$2.57▼ 3.75%Market cap $44.90MP/E —$0.72$20.32
- KPTIKaryopharm Therapeutics Inc. Common Stock$0.39▲ 11.11%Market cap $44.19MP/E —$0.31$10.99
- CNTXContext Therapeutics Inc. Common Stock$0.244▲ 1.24%Market cap $46.31MP/E —$0.2358$3.62
- FLNAFilana Therapeutics Inc. Common Stock$0.7▼ 7.89%Market cap $46.33MP/E —$0.6701$2.27
- MREOMereo BioPharma Group plc American Depositary Shares$0.303▼ 1.94%Market cap $47.46MP/E —$0.2$2.37
- PDSBPDS Biotechnology Corporation Common Stock$1.13▼ 13.08%Market cap $41.78MP/E —$0.1952$1.79
- MCRBSeres Therapeutics Inc. Common Stock$2.46▼ 2.77%Market cap $48.42MP/E —$2.8$29.98
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| EDSA Edesa Biotech Inc. Common Shares | $44.90M | — | $2.57 | ▼ 3.75% | $0.72$20.32 |
| KPTI Karyopharm Therapeutics Inc. Common Stock | $44.19M | — | $0.39 | ▲ 11.11% | $0.31$10.99 |
| CNTX Context Therapeutics Inc. Common Stock | $46.31M | — | $0.244 | ▲ 1.24% | $0.2358$3.62 |
| FLNA Filana Therapeutics Inc. Common Stock | $46.33M | — | $0.7 | ▼ 7.89% | $0.6701$2.27 |
| MREO Mereo BioPharma Group plc American Depositary Shares | $47.46M | — | $0.303 | ▼ 1.94% | $0.2$2.37 |
| PDSB PDS Biotechnology Corporation Common Stock | $41.78M | — | $1.13 | ▼ 13.08% | $0.1952$1.79 |
| MCRB Seres Therapeutics Inc. Common Stock | $48.42M | — | $2.46 | ▼ 2.77% | $2.8$29.98 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Nijhawan Pardeep · October 5, 2026 · Grant6.9K
- Nijhawan Pardeep · September 1, 2026 · Grant5.7K
- Nijhawan Pardeep · August 3, 2026 · Grant5.3K
- Nijhawan Pardeep · July 2, 2026 · Grant3.4K
- Nijhawan Pardeep · June 16, 2026 · Grant153.6K @ $5.21
- Nijhawan Pardeep · June 1, 2026 · Grant1.7K
- Marshall Patrick · May 27, 2026 · Grant19.0K
- MacDonald Sean Arthur · May 27, 2026 · Grant19.0K
- Chypyha Joan · May 27, 2026 · Grant19.0K
- Weiler Peter J. · May 27, 2026 · Grant64.6K
- Brooks Michael J · May 27, 2026 · Grant64.6K
- Sistilli Carlo · May 27, 2026 · Grant19.0K
- Olson Charles V · May 27, 2026 · Grant19.0K
- Nijhawan Pardeep · May 27, 2026 · Grant96.9K
- Liu Da David · May 27, 2026 · Grant19.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 2.61M
- Total value held
- $13.49M
- Institutional holders
- 26
- Unknown827.5K
- Unknown687.5K
- Unknown563.2K
- Unknown115.7K
- Unknown86.0K
- Unknown77.1K
- Unknown38.0K
- Unknown35.0K
- Unknown30.5K
- Unknown30.0K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Edesa Biotech Included in After-Market Movers List
Edesa Biotech was highlighted in a recent list of healthcare stocks showing movement during Thursday's after-market session. The company trades well below its average analyst price target, with a 52-week range spanning from $0.72 to $20.32. This inclusion suggests increased attention from traders monitoring after-hours activity in the sector.
Edesa Biotech Included in After-Market Movers List. Edesa Biotech was highlighted in a recent list of healthcare stocks showing movement during Thursday's after-market session. The company trades well below its average analyst price target, with a 52-week range spanning from $0.72 to $20.32. This inclusion suggests increased attention from traders monitoring after-hours activity in the sector.